ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > IL-10

IL-10

概要

Name:Interleukin-10
Target Synonym:Interleukin 10,IL-10,IL10,CSIF,Cytokine Synthesis Inhibitory Factor,T-Cell Growth Inhibitory Factor,Interleukin-10,GVHDS,IL10A,TGIF
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase 3 Clinical

ライセンス

Project Name Modality Therapeutic Area Indications Stage Right Available
IL10 / IL10RA mAb Monospecific antibody Infectious and parasitic diseases Immunodeficiencies PCC Global

製品リスト製品比較と製品注文

ACRO Quality

生物活性データの一部

IL0-H5219-Cell-based assay
 IL-10 CELL

Human IL-10, premium grade (Cat. No. IL0-H5219) inhibits the secrection IL-6 by RAW264.7 cells. The specific activity of Human IL-10, premium grade is >1.00 x 10^7 IU/mg, which is calibrated against WHO Reference Reagent Interleukin-10 (Human, rDNA derived) (NIBSC code: 93/722) (QC tested).

IL0-M4248-Cell-based assay
 IL-10 CELL

Mouse IL-10, His Tag (Cat. No. IL0-M4248) inhibits LPS-induced secretion of IL-6 by RAW264.7 cells. The EC50 for this effect is 0.27-0.39 ng/mL (Routinely tested).

IL0-H5219-ELISA
 IL-10 ELISA

Immobilized Human IL-10, premium grade (Cat. No. IL0-H5219) at 5 μg/mL (100 μL/well) can bind Biotinylated Human IL-10 R alpha, Fc,Avitag (Cat. No. ILR-H82F6) with a linear range of 0.2-5 ng/mL (QC tested).

IL0-H5219-MALS-HPLC
IL-10 MALS images

The purity of Human IL-10, premium grade (Cat. No. IL0-H5219) is more than 90% and the molecular weight of this protein is around 35-45 kDa verified by SEC-MALS.

カスタマーレビュー

Synonym Name

CSIF,IL-10,IL10A,TGIF,B-TCGF,GVHDS,MGC126450,MGC126451,RP11-262N9.1,Interleukin-10

Background

Interleukin-10 (IL-10) is also known as human cytokine synthesis inhibitory factor (CSIF), is an anti-inflammatory cytokine. IL-10 is an immunosuppressive cytokine produced by a variety of mammalian cell types including macrophages, monocytes, T cells, B cells and keratinocytes. Mature human IL-10 shares 72% - 86% amino acid sequence identity with bovine, canine, equine, feline, mouse, ovine, porcine, and rat IL-10. Whereas human IL-10 is active on mouse cells, mouse IL-10 does not act on human cells. IL-10 is capable of inhibiting synthesis of pro-inflammatory cytokines such as IFN-γ, IL-2, IL-3, TNFα and GM-CSF made by cells such as macrophages and regulatory T-cells. It also displays a potent ability to suppress the antigen-presentation capacity of antigen presenting cells. However, it is also stimulatory towards certain T cells and mast cells and stimulates B cell maturation and antibody production. Knockout studies suggested the function of Interleukin-10 / IL-10 as an essential immunoregulator in the intestinal tract. Patients with Crohn's disease react favorably towards treatment with bacteria producing recombinant interleukin-10, showing the importance of interleukin-10 for counteracting excessive immunity in the human body.

Clinical and Translational Updates

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
Mesenchymal stem cells therapy (Therapeutic Solutions International) Phase 3 Clinical Jadi Cell LLC Coronavirus Disease 2019 (COVID-19) Details
KLS-2031 KLS-2031 Phase 2 Clinical Kolon Life Science. Inc Radiculopathy Details
WP-1303 (worgpharma) ATX-MS-1467; ATX-MS-01; M-2736; WP-1303; MSC-2358825A Phase 2 Clinical Apitope Technology Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis; Multiple Myeloma Details
XT-150 XT-101-R; XT-101; XT-150 Phase 2 Clinical Xalud Therapeutics Inc Multiple Sclerosis; Neuralgia; Back Pain; Osteoarthritis, Knee; Arthralgia; Inflammation; Osteoarthritis, Spine Details

This web search service is supported by Google Inc.

totopphone